Evaluation of Drug Targeting Strategies and Liposomal Trafficking.
Authors: Oku, N.; Tokudome, Y.; Asai, T.; Tsukada, H.
Source: Current Pharmaceutical Design, Volume 6, Number 16, 1 November 2000 , pp. 1669-1691(23)
Publisher: Bentham Science Publishers
Abstract:
Liposomes, that are biodegradable and essentially non-toxic, can encapsulate both hydrophilic and hydrophobic materials, and are utilized as drug carriers for drug delivery systems (DDS). Recent progress in gene technology provides a novel modality of therapy for various diseases with a variety of newly-developed cationic liposomes. Delivery of agents to the reticuloendothelial system (RES) is easily achieved since most conventional liposomes are trapped by the RES. For the purpose of delivery of agents to target organs other than RES, long-circulating liposomes have been developed by modifying the liposomal surface. Understanding of the in vivo dynamics of liposome-carried agents is required to evaluate the bioavailability of drugs encapsulated in liposomes. In this review, we focus on the in vivo trafficking of liposomes visualized by positron emission tomography (PET) and discuss the characteristics of liposomes that affect the targeting of drugs in vivo.Keywords: Liposomal Trafficking; Drug delivery system(DDS); Anti-sense oligo-deoxynucleotide(ODN); Long Circulating liposomes; PEG-liposomes; PEG coating; antibody-AmBisome; RES-trapping; Liposomal
Document Type: Review article
DOI: http://dx.doi.org/10.2174/1381612003398816
Publication date: 2000-11-01
- Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.
Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.
- In this: publication
- By this: publisher
- In this Subject: Pharmacology
- By this author: Oku, N. ; Tokudome, Y. ; Asai, T. ; Tsukada, H.

Shopping cart
Receive new issue alert
Get Permissions